A new study demonstrates a promising therapeutic approach for treating glioblastoma, an aggressive form of brain cancer. Researchers have developed a virus-based therapy that is injected directly into the tumor. The modified virus selectively infects and kills cancer cells while simultaneously triggering a powerful, targeted immune response. This dual-action approach not only attacks the primary tumor but also trains the immune system to recognize and eliminate remaining cancer cells throughout the body. Early-stage clinical trials show the treatment is safe and has extended survival in some patients with recurrent glioblastoma, offering new hope for a condition with very limited treatment options. Read the full article at: https://www.sciencedaily.com/releases/2026/03/260319044708.htm